Trial intelligence / Profile preview

Phase II randomized double-blind double-dummy three-arm trial of YFZ-003 for pediatric acute tonsillitis (wind-heat syndrome)

CTR20261415Phase 2Active

Sponsor
Sichuan Kaijing Pharmaceutical
Start
Jun 2026
Countries
1
01

Overview

A Phase 2 trial of YFZ-003 in acute tonsillitis, sponsored by Sichuan Kaijing Pharmaceutical. Started Jun 2026; status: active.

02

Drugs

YFZ-003
03

Conditions

acute tonsillitis

Beyond the preview

Go deeper on CTR20261415.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20261415.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call